On April 29, 2024, the US Federal Trade Commission ordered Razer, the Singapore-founded gaming hardware giant, to pay more than US$1.1 million over its marketing of the Zephyr face mask, finding that the company had falsely sold the product as N95-grade during the pandemic without ever having it tested. The settlement required Razer to surrender US$1,071,254.33, the full amount of its US profits from the mask, for consumer refunds, plus a US$100,000 civil penalty.
The Zephyr had been one of the pandemic's most eye-catching gadgets: a transparent, twin-fan mask with RGB lighting that looked more like cyberpunk cosplay gear than medical equipment. Launched in October 2021 after nearly a year of internet hype, it was sold for between US$99 and US$149.99 and marketed aggressively on the company's website, TikTok and YouTube as an N95 or N95-equivalent mask offering protection against COVID-19. Co-founder and CEO Min-Liang Tan repeatedly linked the mask to the rise of the Delta variant, making explicit health claims and suggesting certification was being sought. According to the FTC's complaint, the company knew it had never submitted the mask for testing to either the Food and Drug Administration or the National Institute for Occupational Safety and Health, and had never received permission to use the term N95.
Razer only walked back the claims in January 2022, after negative press coverage and consumer backlash, acknowledging that the wearable was not a medical device and scrubbing references to N95-grade filters from its marketing. A planned US$150 Zephyr Pro with voice amplification never made it to market. In settling, Razer said it disagreed with the FTC's allegations and admitted no wrongdoing, describing the settlement as a way to avoid the distraction of litigation, and noted that it had proactively notified customers, stopped sales and issued refunds more than two years earlier.
The FTC was unmoved. Its Bureau of Consumer Protection director said the company had falsely claimed, in the midst of a global pandemic, that its mask was the equivalent of a certified respirator, and vowed to keep holding businesses accountable for false health claims. The order also bars Razer from making COVID-related health claims or unsubstantiated health-benefit claims in the future. For a brand built on gamer trust, the episode was a costly lesson in what happens when a tech company accustomed to moving fast wanders into a regulated industry where the stakes are measured in lives.
The settlement's terms went beyond the money. Razer was banned from making COVID-related health misrepresentations and from claiming its products were affiliated with, endorsed by or certified by any government entity without reliable scientific evidence, and from marketing health benefits without proper substantiation. The company pushed back in its public response, suggesting the FTC's complaint had cherry-picked limited portions of its statements and stressing that it had gone out of its way to refund customers and end sales of the Zephyr. While the US$100,000 civil penalty was modest for a company of Razer's size, the reputational damage was harder to quantify: a brand that had built its identity on gamer community trust had been found by a federal regulator to have misled consumers about their health and safety during a pandemic. A planned Zephyr Pro, a US$150 version with voice amplification, never reached the market, and the Zephyr episode remains a cautionary tale for tech companies tempted to rebrand themselves as health innovators.